-
Signature
-
/s/ Ali Olivo, Attorney-in-Fact
-
Issuer symbol
-
NEO
-
Transactions as of
-
10 Aug 2023
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
14 Aug 2023, 17:37:27 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| holding |
NEO |
Common Stock |
|
|
|
|
|
56,174 |
10 Aug 2023 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
NEO |
Stock Option (Right to Buy) |
Award |
$0 |
+8,353 |
|
$0.000000 |
8,353 |
10 Aug 2023 |
Common Stock |
8,353 |
$14.82 |
Direct |
|
| transaction |
NEO |
Restricted Stock Unit |
Award |
$0 |
+11,336 |
|
$0.000000 |
11,336 |
10 Aug 2023 |
Common Stock |
11,336 |
$0.000000 |
Direct |
F1 |
| holding |
NEO |
Stock Option (Right to Buy) |
|
|
|
|
|
2,136 |
10 Aug 2023 |
Common Stock |
2,136 |
$22.52 |
Direct |
|
| holding |
NEO |
Stock Option (Right to Buy) |
|
|
|
|
|
3,448 |
10 Aug 2023 |
Common Stock |
3,448 |
$28.54 |
Direct |
|
| holding |
NEO |
Stock Option (Right to Buy) |
|
|
|
|
|
3,714 |
10 Aug 2023 |
Common Stock |
3,714 |
$40.90 |
Direct |
|
| holding |
NEO |
Stock Option (Right to Buy) |
|
|
|
|
|
972 |
10 Aug 2023 |
Common Stock |
972 |
$41.76 |
Direct |
|
| holding |
NEO |
Stock Option (Right to Buy) |
|
|
|
|
|
13,882 |
10 Aug 2023 |
Common Stock |
13,882 |
$8.10 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: